MTOR and acute myeloid leukemia: Nevertheless, the results showed that the high mTOR expression is associated with reduced overall survival compared to the low mTOR group, indicating that high mTOR expression in AML patients increases the hazard of death compared to low expression (Fig. 2F, HR = 1.6, p = 0.11).